IRCT20181023041439N1CompletedPhase 3
Evaluation of zinc supplementation with treatment of children with urinary tract infection
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 52
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 3 years to 12 years (—)
- Sex
- All
Inclusion Criteria
- •3 to12 years old
- •Urinary tract infection(Pyelonephritis)
Exclusion Criteria
- •Change in treatment
- •Personal satisfaction
- •Incorrect use of drug
Investigators
Similar Trials
Completed
Phase 2
Evaluation of the effectiveness of zinc supplementation in children with urinary tract infectiorinary tract infection.Urinary tract infection, site not specifiedIRCT138903094056N1Arak University of Medical Sciences200
Completed
Phase 2
Assessment the effect of zinc supplementation on adverse outcomes of pregnancyAdverse outcomes of pregnancy.Fetus and newborn affected by maternal nutritional disordersIRCT138707161306N1Research vice chancellorship-Guilan university of Medical Science500
Recruiting
Phase 4
Investigating the effect of finasteride and zinc supplement on hair loss after covid-19 infectioIRCT20230531058350N1Islamic Azad University64
Recruiting
Phase 3
Investigating the effects of zinc in reducing the risk of diabetes and cardiovascular diseasesIRCT20240125060804N1Islamic Azad University60
Completed
Phase 2
Investigating the effect of zinc supplementation on the frequency and duration of colds in children aged 6 to 10 yearsCold.Other viral pneumoniaJ12.8IRCT20230902059330N1Islamic Azad University50